Although a classical proinflammatory cytokine TNF-α has been previously shown to have potent beneficial effects in autoimmune neurodegeneration [28], reported herein increase in concentration of serum TNF-α in treated patients with MS had likely no protective input. This evidence concerns the gene TNF and myeloid sarcoma.